BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18365797)

  • 1. Adding motivational interviewing to exposure and ritual prevention for obsessive-compulsive disorder: an open pilot trial.
    Simpson HB; Zuckoff A; Page JR; Franklin ME; Foa EB
    Cogn Behav Ther; 2008; 37(1):38-49. PubMed ID: 18365797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges using motivational interviewing as an adjunct to exposure therapy for obsessive-compulsive disorder.
    Simpson HB; Zuckoff AM; Maher MJ; Page JR; Franklin ME; Foa EB; Schmidt AB; Wang Y
    Behav Res Ther; 2010 Oct; 48(10):941-8. PubMed ID: 20609435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive behavioral therapy plus motivational interviewing improves outcome for pediatric obsessive-compulsive disorder: a preliminary study.
    Merlo LJ; Storch EA; Lehmkuhl HD; Jacob ML; Murphy TK; Goodman WK; Geffken GR
    Cogn Behav Ther; 2010; 39(1):24-7. PubMed ID: 19675960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial.
    Simpson HB; Gorfinkle KS; Liebowitz MR
    J Clin Psychiatry; 1999 Sep; 60(9):584-90. PubMed ID: 10520976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability, Feasibility, and Effectiveness of Internet-Based Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder in New York.
    Patel SR; Wheaton MG; Andersson E; Rück C; Schmidt AB; La Lima CN; Galfavy H; Pascucci O; Myers RW; Dixon LB; Simpson HB
    Behav Ther; 2018 Jul; 49(4):631-641. PubMed ID: 29937263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient adherence predicts outcome from cognitive behavioral therapy in obsessive-compulsive disorder.
    Simpson HB; Maher MJ; Wang Y; Bao Y; Foa EB; Franklin M
    J Consult Clin Psychol; 2011 Apr; 79(2):247-252. PubMed ID: 21355639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of symptom dimensions on outcome for exposure and ritual prevention therapy in obsessive-compulsive disorder.
    Williams MT; Farris SG; Turkheimer EN; Franklin ME; Simpson HB; Liebowitz M; Foa EB
    J Anxiety Disord; 2014 Aug; 28(6):553-8. PubMed ID: 24983796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximizing remission from cognitive-behavioral therapy in medicated adults with obsessive-compulsive disorder.
    Simpson HB; Foa EB; Wheaton MG; Gallagher T; Gershkovich M; Schmidt AB; Huppert JD; Campeas RB; Imms PA; Cahill SP; DiChiara C; Tsao SD; Puliafico AC; Chazin D; Asnaani A; Moore K; Tyler J; Steinman SA; Sanchez-LaCay A; Capaldi S; Snorrason I; Turk-Karan E; Vermes D; Kalanthroff E; Pinto A; Hahn CG; Xu B; Van Meter PE; Katechis M; Scodes J; Wang Y
    Behav Res Ther; 2021 Aug; 143():103890. PubMed ID: 34089924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adding motivational interviewing and thought mapping to cognitive-behavioral group therapy: results from a randomized clinical trial.
    Meyer E; Shavitt RG; Leukefeld C; Heldt E; Souza FP; Knapp P; Cordioli AV
    Braz J Psychiatry; 2010 Mar; 32(1):20-9. PubMed ID: 20339731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Internet-based cognitive behavior therapy for obsessive compulsive disorder: a pilot study.
    Andersson E; Ljótsson B; Hedman E; Kaldo V; Paxling B; Andersson G; Lindefors N; Rück C
    BMC Psychiatry; 2011 Aug; 11():125. PubMed ID: 21812991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Task-based fMRI predicts response and remission to exposure therapy in obsessive-compulsive disorder.
    Pagliaccio D; Middleton R; Hezel D; Steinman S; Snorrason I; Gershkovich M; Campeas R; Pinto A; Van Meter P; Simpson HB; Marsh R
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20346-20353. PubMed ID: 31548396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response versus remission in obsessive-compulsive disorder.
    Simpson HB; Huppert JD; Petkova E; Foa EB; Liebowitz MR
    J Clin Psychiatry; 2006 Feb; 67(2):269-76. PubMed ID: 16566623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating Exposure and Response Prevention With a Mobile App to Treat Obsessive-Compulsive Disorder: Feasibility, Acceptability, and Preliminary Effects.
    Gershkovich M; Middleton R; Hezel DM; Grimaldi S; Renna M; Basaraba C; Patel S; Simpson HB
    Behav Ther; 2021 Mar; 52(2):394-405. PubMed ID: 33622508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EFFECTS OF HOMEWORK COMPLIANCE ON COGNITIVE-BEHAVIORAL THERAPY WITH D-CYCLOSERINE AUGMENTATION FOR CHILDREN WITH OBSESSIVE COMPULSIVE DISORDER.
    Olatunji BO; Rosenfield D; Monzani B; Krebs G; Heyman I; Turner C; Isomura K; Mataix-Cols D
    Depress Anxiety; 2015 Dec; 32(12):935-43. PubMed ID: 26372401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized clinical trial to examine enhancing cognitive-behavioral group therapy for obsessive-compulsive disorder with motivational interviewing and thought mapping.
    Meyer E; Souza F; Heldt E; Knapp P; Cordioli A; Shavitt RG; Leukefeld C
    Behav Cogn Psychother; 2010 May; 38(3):319-36. PubMed ID: 20353621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral avoidance predicts treatment outcome with exposure and response prevention for obsessive-compulsive disorder.
    Wheaton MG; Gershkovich M; Gallagher T; Foa EB; Simpson HB
    Depress Anxiety; 2018 Mar; 35(3):256-263. PubMed ID: 29394511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Motivation Impact OCD Symptom Severity? An Exploration of Longitudinal Effects.
    Ponzini G; Van Kirk N; Schreck M; Nota JA; Schofield CA; Gironda C; Elias J
    Behav Ther; 2019 Mar; 50(2):300-313. PubMed ID: 30824247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of Motivational Interviewing in Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder.
    Guzick AG; McCabe RE; Storch EA
    J Cogn Psychother; 2021 May; 35(2):116-132. PubMed ID: 33990444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of cognitive behavioural therapy with medication for patients with obsessive-compulsive disorder: A multicentre randomised controlled trial in China.
    Meng FQ; Han HY; Luo J; Liu J; Liu ZR; Tang Y; Hou X; Wei J; Shi LL; Tang MN; Yan YP; Huang YQ; Sun J; Li ZJ
    J Affect Disord; 2019 Jun; 253():184-192. PubMed ID: 31108379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a patient adherence scale for exposure and response prevention therapy.
    Simpson HB; Maher M; Page JR; Gibbons CJ; Franklin ME; Foa EB
    Behav Ther; 2010 Mar; 41(1):30-7. PubMed ID: 20171325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.